Your browser doesn't support javascript.
loading
New Therapeutic Horizons in Chronic Kidney Disease: The Role of SGLT2 Inhibitors in Clinical Practice.
Evans, Marc; Morgan, Angharad R; Whyte, Martin B; Hanif, Wasim; Bain, Stephen C; Kalra, Philip A; Davies, Sarah; Dashora, Umesh; Yousef, Zaheer; Patel, Dipesh C; Strain, W David.
Afiliación
  • Evans M; Diabetes Resource Centre, University Hospital Llandough, Penlan Road, Llandough Cardiff, CF64 2XX, UK. marclyndon1@hotmail.com.
  • Morgan AR; Health Economics and Outcomes Research Ltd, Cardiff, UK.
  • Whyte MB; Faculty of Health and Medical Sciences, University of Surrey, Guildford, UK.
  • Hanif W; University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
  • Bain SC; Diabetes Research Unit, Swansea University Medical School, Swansea, UK.
  • Kalra PA; Salford Royal NHS Foundation Trust, Northern Care Alliance NHS Group, Salford, UK.
  • Davies S; Woodlands Medical Centre, Cardiff, UK.
  • Dashora U; East Sussex Healthcare NHS Trust, Seaford, UK.
  • Yousef Z; Department of Cardiology, University Hospital of Wales and Cardiff University, Cardiff, UK.
  • Patel DC; Division of Medicine, Department of Diabetes, University College London, Royal Free Campus, London, UK.
  • Strain WD; Diabetes and Vascular Research Centre, University of Exeter Medical School, Exeter, UK.
Drugs ; 82(2): 97-108, 2022 Feb.
Article en En | MEDLINE | ID: mdl-34932209

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Insuficiencia Renal Crónica / Inhibidores del Cotransportador de Sodio-Glucosa 2 Tipo de estudio: Clinical_trials / Guideline Límite: Humans Idioma: En Revista: Drugs Año: 2022 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Insuficiencia Renal Crónica / Inhibidores del Cotransportador de Sodio-Glucosa 2 Tipo de estudio: Clinical_trials / Guideline Límite: Humans Idioma: En Revista: Drugs Año: 2022 Tipo del documento: Article País de afiliación: Reino Unido